Market Overview:
The global oral guided bone regeneration (GBR) and guided tissue regeneration (GTR) membrane market is expected to register a CAGR of 7.8% during the forecast period, 2018-2030. The market growth can be attributed to the increasing demand for oral GBR and GTR membranes in human pharmaceutical and veterinary health applications. Additionally, rising awareness about benefits of oral GBR and GTR membranes is also propelling the market growth. However, high cost associated with these products may hamper the market growth in some regions. Based on type, the global oral guided bone regeneration (GBR) and guided tissue regeneration (GTR) membrane market is segmented into extraction membranes and squeeze membranes. Extraction membranes are further classified into collagen-based extraction membranes and synthetic extraction membranes; while squeeze Membranes are further classified into collagen-based squeeze Membranesand synthetic squeeze Membranes .
 and Guided Tissue Regeneration (GTR) Membrane Industry Outlook.svg)
Product Definition:
Oral guided bone regeneration (GBR) and guided tissue regeneration (GTR) membrane are biologic membranes that have been used to promote the healing of extensive bone and periodontal defects. These membranes are placed in direct contact with the wound, where they provide a physical and biochemical barrier to infection while promoting the growth of new tissue.
Extraction:
Extraction is a surgical procedure wherein the bone graft or bone chips are taken from the patient's body and used to stimulate healing of damaged areas. It has been observed that extraction of large amount of bone grafts from the patient’s body increases risk for infection, whereas small amount of extracts cause inadequate regeneration leading to failure. Thus, it is important to control both factors i.e.
Squeeze:
The human body is capable of regenerating itself, however, the process is slow and inefficient. The body’s natural tendency is to replace damaged cells and tissues with new cells and tissues formed from the same type of tissue. For instance; if a bone is broken it will form a new bone to replace the old one but sometimes this process takes longer than expected or cannot happen in some cases such as tumor or infection which needs surgical removal or biopsy for diagnosis.
Application Insights:
The application segment includes human pharmaceutical and veterinary health. In 2017, the human pharmaceutical segment dominated the global market with a revenue share of over 60%. The use of these products in surgeries such as total hip replacement and knee replacement is increasing significantly. Moreover, there are various clinical trials that support its usage in treating oral conditions such as periodontitis and osteoarthritis.
On the other hand, GBR has been used for centuries by veterinarians to treat orthopedic disorders in animals including dogs & cats, horses & ponies, cattle & buffalos) owing to their ability to regenerate bone tissue at a faster rate than conventional therapies or surgery. Furthermore, it also helps stimulate new bone formation which results in reduction of inflammation along with pain relief after surgery.
Regional Analysis:
Europe dominated the global market in 2017 owing to the presence of a large number of bone and tissue regenerative medicine manufacturers. The region is expected to maintain its dominance over the forecast period due to increasing R&D investments by companies and universities for development of advanced GBR products. In addition, growing prevalence of osteoporosis coupled with high adoption rate for new technologies are some other factors contributing toward growth in this region.
Asia Pacific is anticipated to witness lucrative growth during the forecast period owing to rising disposable income, improving healthcare infrastructure, and availability of effective treatment at affordable costs in emerging economies such as China & India. Furthermore, supportive government initiatives aimed at promoting medical tourism are expected drive regional market expansion over next eight years.
Growth Factors:
- Increasing demand for dental implants and tooth replacement procedures
- Rising geriatric population with increasing incidence of oral diseases
- Growing awareness about benefits of Oral GBR/GTR membrane procedures
- Technological advancements in Oral GBR/GTR membrane products and procedures
- Increasing healthcare expenditure by private players and government bodies
Scope Of The Report
Report Attributes
Report Details
Report Title
Oral Guided Bone Regeneration (GBR) and Guided Tissue Regeneration (GTR) Membrane Market Research Report
By Type
Extraction, Squeeze
By Application
Human Pharmaceutical, Veterinary Health
By Companies
Guangzhou Hanfang Pharmaceutical Co., Ltd, ADM-SIO, Zhejiang Tianyushan Medicinal Oil, Xinxing Pharma, Kamakhya Bottlers, Wuhan Haishan Technology Co., Ltd.
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
222
Number of Tables & Figures
156
Customization Available
Yes, the report can be customized as per your need.
Global Oral Guided Bone Regeneration (GBR) and Guided Tissue Regeneration (GTR) Membrane Market Report Segments:
The global Oral Guided Bone Regeneration (GBR) and Guided Tissue Regeneration (GTR) Membrane market is segmented on the basis of:
Types
Extraction, Squeeze
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Human Pharmaceutical, Veterinary Health
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- Guangzhou Hanfang Pharmaceutical Co., Ltd
- ADM-SIO
- Zhejiang Tianyushan Medicinal Oil
- Xinxing Pharma
- Kamakhya Bottlers
- Wuhan Haishan Technology Co., Ltd.
 and Guided Tissue Regeneration (GTR) Membrane Market Overview.svg)
Highlights of The Oral Guided Bone Regeneration (GBR) and Guided Tissue Regeneration (GTR) Membrane Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Extraction
- Squeeze
- By Application:
- Human Pharmaceutical
- Veterinary Health
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Oral Guided Bone Regeneration (GBR) and Guided Tissue Regeneration (GTR) Membrane Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
 and Guided Tissue Regeneration (GTR) Membrane Market Statistics.svg)
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
Oral guided bone regeneration (GBR) and guided tissue regeneration (GTR) membrane are medical devices that use a combination of manual and electrical stimulation to help regenerate damaged or diseased tissues. The devices work by directing the growth of new cells into the damaged area, which can then repair or replace the damaged tissue.
Some of the key players operating in the oral guided bone regeneration (gbr) and guided tissue regeneration (gtr) membrane market are Guangzhou Hanfang Pharmaceutical Co., Ltd, ADM-SIO, Zhejiang Tianyushan Medicinal Oil, Xinxing Pharma, Kamakhya Bottlers, Wuhan Haishan Technology Co., Ltd..
The oral guided bone regeneration (gbr) and guided tissue regeneration (gtr) membrane market is expected to grow at a compound annual growth rate of 7.8%.
Chapter 1 Executive Summary
Chapter 2 Assumptions and Acronyms Used
Chapter 3 Research Methodology
Chapter 4 Oral Guided Bone Regeneration (GBR) and Guided Tissue Regeneration (GTR) Membrane Market Overview
4.1 Introduction
4.1.1 Market Taxonomy
4.1.2 Market Definition
4.1.3 Macro-Economic Factors Impacting the Market Growth
4.2 Oral Guided Bone Regeneration (GBR) and Guided Tissue Regeneration (GTR) Membrane Market Dynamics
4.2.1 Market Drivers
4.2.2 Market Restraints
4.2.3 Market Opportunity
4.3 Oral Guided Bone Regeneration (GBR) and Guided Tissue Regeneration (GTR) Membrane Market - Supply Chain Analysis
4.3.1 List of Key Suppliers
4.3.2 List of Key Distributors
4.3.3 List of Key Consumers
4.4 Key Forces Shaping the Oral Guided Bone Regeneration (GBR) and Guided Tissue Regeneration (GTR) Membrane Market
4.4.1 Bargaining Power of Suppliers
4.4.2 Bargaining Power of Buyers
4.4.3 Threat of Substitution
4.4.4 Threat of New Entrants
4.4.5 Competitive Rivalry
4.5 Global Oral Guided Bone Regeneration (GBR) and Guided Tissue Regeneration (GTR) Membrane Market Size & Forecast, 2020-2028
4.5.1 Oral Guided Bone Regeneration (GBR) and Guided Tissue Regeneration (GTR) Membrane Market Size and Y-o-Y Growth
4.5.2 Oral Guided Bone Regeneration (GBR) and Guided Tissue Regeneration (GTR) Membrane Market Absolute $ Opportunity
Chapter 5 Global Market Analysis and Forecast by Type
5.1 Introduction
5.1.1 Key Market Trends & Growth Opportunities by Type
5.1.2 Basis Point Share (BPS) Analysis by Type
5.1.3 Absolute $ Opportunity Assessment by Type
5.2 Market Size Forecast by Type
5.2.1 Extraction
5.2.2 Squeeze
5.3 Market Attractiveness Analysis by Type
Chapter 6 Global Market Analysis and Forecast by Applications
6.1 Introduction
6.1.1 Key Market Trends & Growth Opportunities by Applications
6.1.2 Basis Point Share (BPS) Analysis by Applications
6.1.3 Absolute $ Opportunity Assessment by Applications
6.2 Market Size Forecast by Applications
6.2.1 Human Pharmaceutical
6.2.2 Veterinary Health
6.3 Market Attractiveness Analysis by Applications
Chapter 7 Global Oral Guided Bone Regeneration (GBR) and Guided Tissue Regeneration (GTR) Membrane Market Analysis and Forecast by Region
7.1 Introduction
7.1.1 Key Market Trends & Growth Opportunities by Region
7.1.2 Basis Point Share (BPS) Analysis by Region
7.1.3 Absolute $ Opportunity Assessment by Region
7.2 Oral Guided Bone Regeneration (GBR) and Guided Tissue Regeneration (GTR) Membrane Market Size Forecast by Region
7.2.1 North America
7.2.2 Europe
7.2.3 Asia Pacific
7.2.4 Latin America
7.2.5 Middle East & Africa (MEA)
7.3 Market Attractiveness Analysis by Region
Chapter 8 Coronavirus Disease (COVID-19) Impact
8.1 Introduction
8.2 Current & Future Impact Analysis
8.3 Economic Impact Analysis
8.4 Government Policies
8.5 Investment Scenario
Chapter 9 North America Analysis and Forecast
9.1 Introduction
9.2 North America Market Size Forecast by Country
9.2.1 U.S.
9.2.2 Canada
9.3 Basis Point Share (BPS) Analysis by Country
9.4 Absolute $ Opportunity Assessment by Country
9.5 Market Attractiveness Analysis by Country
9.6 North America Market Size Forecast by Type
9.6.1 Extraction
9.6.2 Squeeze
9.7 Basis Point Share (BPS) Analysis by Type
9.8 Absolute $ Opportunity Assessment by Type
9.9 Market Attractiveness Analysis by Type
9.10 North America Market Size Forecast by Applications
9.10.1 Human Pharmaceutical
9.10.2 Veterinary Health
9.11 Basis Point Share (BPS) Analysis by Applications
9.12 Absolute $ Opportunity Assessment by Applications
9.13 Market Attractiveness Analysis by Applications
Chapter 10 Europe Analysis and Forecast
10.1 Introduction
10.2 Europe Market Size Forecast by Country
10.2.1 Germany
10.2.2 France
10.2.3 Italy
10.2.4 U.K.
10.2.5 Spain
10.2.6 Russia
10.2.7 Rest of Europe
10.3 Basis Point Share (BPS) Analysis by Country
10.4 Absolute $ Opportunity Assessment by Country
10.5 Market Attractiveness Analysis by Country
10.6 Europe Market Size Forecast by Type
10.6.1 Extraction
10.6.2 Squeeze
10.7 Basis Point Share (BPS) Analysis by Type
10.8 Absolute $ Opportunity Assessment by Type
10.9 Market Attractiveness Analysis by Type
10.10 Europe Market Size Forecast by Applications
10.10.1 Human Pharmaceutical
10.10.2 Veterinary Health
10.11 Basis Point Share (BPS) Analysis by Applications
10.12 Absolute $ Opportunity Assessment by Applications
10.13 Market Attractiveness Analysis by Applications
Chapter 11 Asia Pacific Analysis and Forecast
11.1 Introduction
11.2 Asia Pacific Market Size Forecast by Country
11.2.1 China
11.2.2 Japan
11.2.3 South Korea
11.2.4 India
11.2.5 Australia
11.2.6 South East Asia (SEA)
11.2.7 Rest of Asia Pacific (APAC)
11.3 Basis Point Share (BPS) Analysis by Country
11.4 Absolute $ Opportunity Assessment by Country
11.5 Market Attractiveness Analysis by Country
11.6 Asia Pacific Market Size Forecast by Type
11.6.1 Extraction
11.6.2 Squeeze
11.7 Basis Point Share (BPS) Analysis by Type
11.8 Absolute $ Opportunity Assessment by Type
11.9 Market Attractiveness Analysis by Type
11.10 Asia Pacific Market Size Forecast by Applications
11.10.1 Human Pharmaceutical
11.10.2 Veterinary Health
11.11 Basis Point Share (BPS) Analysis by Applications
11.12 Absolute $ Opportunity Assessment by Applications
11.13 Market Attractiveness Analysis by Applications
Chapter 12 Latin America Analysis and Forecast
12.1 Introduction
12.2 Latin America Market Size Forecast by Country
12.2.1 Brazil
12.2.2 Mexico
12.2.3 Rest of Latin America (LATAM)
12.3 Basis Point Share (BPS) Analysis by Country
12.4 Absolute $ Opportunity Assessment by Country
12.5 Market Attractiveness Analysis by Country
12.6 Latin America Market Size Forecast by Type
12.6.1 Extraction
12.6.2 Squeeze
12.7 Basis Point Share (BPS) Analysis by Type
12.8 Absolute $ Opportunity Assessment by Type
12.9 Market Attractiveness Analysis by Type
12.10 Latin America Market Size Forecast by Applications
12.10.1 Human Pharmaceutical
12.10.2 Veterinary Health
12.11 Basis Point Share (BPS) Analysis by Applications
12.12 Absolute $ Opportunity Assessment by Applications
12.13 Market Attractiveness Analysis by Applications
Chapter 13 Middle East & Africa (MEA) Analysis and Forecast
13.1 Introduction
13.2 Middle East & Africa (MEA) Market Size Forecast by Country
13.2.1 Saudi Arabia
13.2.2 South Africa
13.2.3 UAE
13.2.4 Rest of Middle East & Africa (MEA)
13.3 Basis Point Share (BPS) Analysis by Country
13.4 Absolute $ Opportunity Assessment by Country
13.5 Market Attractiveness Analysis by Country
13.6 Middle East & Africa (MEA) Market Size Forecast by Type
13.6.1 Extraction
13.6.2 Squeeze
13.7 Basis Point Share (BPS) Analysis by Type
13.8 Absolute $ Opportunity Assessment by Type
13.9 Market Attractiveness Analysis by Type
13.10 Middle East & Africa (MEA) Market Size Forecast by Applications
13.10.1 Human Pharmaceutical
13.10.2 Veterinary Health
13.11 Basis Point Share (BPS) Analysis by Applications
13.12 Absolute $ Opportunity Assessment by Applications
13.13 Market Attractiveness Analysis by Applications
Chapter 14 Competition Landscape
14.1 Oral Guided Bone Regeneration (GBR) and Guided Tissue Regeneration (GTR) Membrane Market: Competitive Dashboard
14.2 Global Oral Guided Bone Regeneration (GBR) and Guided Tissue Regeneration (GTR) Membrane Market: Market Share Analysis, 2019
14.3 Company Profiles (Details – Overview, Financials, Developments, Strategy)
14.3.1 Guangzhou Hanfang Pharmaceutical Co., Ltd
14.3.2 ADM-SIO
14.3.3 Zhejiang Tianyushan Medicinal Oil
14.3.4 Xinxing Pharma
14.3.5 Kamakhya Bottlers
14.3.6 Wuhan Haishan Technology Co., Ltd.
